Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
Background: After radical prostatectomy (RP), depending on stage, up to 40% of patients with prostate cancer (PCa) will experience biochemical failure (BF). Despite salvage therapy, approximately one-third of these patients will need permanent hormone therapy (pHT) and are at risk of progression to...
Main Authors: | Ingrid Jenny Guldvik, Peder Rustøen Braadland, Shivanthe Sivanesan, Håkon Ramberg, Gitte Kristensen, Pierre Tennstedt, Andreas Røder, Thorsten Schlomm, Viktor Berge, Lars Magne Eri, Wolfgang Lilleby, Ian G. Mills, Kristin Austlid Taskén |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | European Urology Open Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168322019000 |
Similar Items
-
Low blood levels of LRG1 before radical prostatectomy identify patients with high risk of progression to castration-resistant prostate cancer
by: Guldvik, IJ, et al.
Published: (2022) -
β-Adrenergic receptor signaling in prostate cancer
by: Peder Rustøen Braadland, et al.
Published: (2015-01-01) -
LRG1: an emerging player in disease pathogenesis
by: Carlotta Camilli, et al.
Published: (2022-01-01) -
Acetate and Potassium Modulate the Stationary-Phase Activation of lrgAB in Streptococcus mutans
by: Sang-Joon Ahn, et al.
Published: (2020-03-01) -
LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents
by: Rashed Alhammad, et al.
Published: (2023-07-01)